No insider purchase over the last 90 days. The latest was filed 17 May 2022.
This page follows insider dealings at Danaher Corp /DE/ as filed with SEC (Form 4) based in Washington, D.C., United States. The group dates from 1981. 19 insiders have disclosed 61 filings since 18 October 2025.
The flow runs one way only: 6 sales worth €80.4M, from 2 insiders, and no purchase. At €57.5M, the sale published on 4 November 2025 by Rales Mitchell P is the largest of the period.
For context, the typical company on the same exchange (median of 5,812 companies) published 19 filings over the same period, against 61 filings here. Looking back to 2016, when coverage begins, insiders filed 1 purchase and 37 sales. The 10-K for the year ended 31 December 2025 shows 24.57 bn USD of revenue and 3.61 bn USD of net income.
Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.
Other companies in the same market with recent insider buying flagged by our signals: GameStop Corp. and Heico Corp. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Analysts rate Danaher Corp /DE/ Strong Buy (bullish), based on 23 analysts. Average price target: US$230.83.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 297 declarations
Danaher Corp is an American company that specializes in the manufacturing of scientific and technological products. It operates in various sectors, including biotechnology and measurement instruments.
Purchases our model currently ranks for the recommendations list.
All recommendationsInsider filings
Over the last 90 days, 11 filings published between 6 August and 14 October 2026: 3 sales for €10.9M. 8 other filings (not open-market purchases or sales: grants, options, plans, sale notices, block transfers). Largest amounts: Blair Rainer (President & CEO), sales of €10.9M.
Summary written automatically from public filings, without human review. General information, identical for every reader: it is not investment advice or a recommendation to buy or sell. Investing involves a risk of capital loss. Generated on 15 October 2026 (UTC)
Headquarters: Washington, D.C., United States · Founded: 1981 · Wikipedia article
Source: Wikidata (CC0).
| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Dec 2025 | 24.57 bn USD | 3.61 bn USD | 5.05 USD | 10-K |
| Dec 2024 | 23.88 bn USD | 3.90 bn USD | 5.29 USD | 10-K |
| Dec 2023 | 23.89 bn USD | 4.76 bn USD | 6.38 USD | 10-K |
| Dec 2022 | 26.64 bn USD | 7.21 bn USD | 9.66 USD | 10-K |
| Dec 2021 | 24.80 bn USD | 6.43 bn USD | 8.61 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.